Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) Return on Capital Employed (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Return on Capital Employed over the past 15 years, most recently at 0.08% for Q2 2025.

  • Quarterly results put Return on Capital Employed at 0.08% for Q2 2025, down 4.0% from a year ago — trailing twelve months through May 2025 was 0.08% (down 4.0% YoY), and the annual figure for FY2025 was 0.08%, down 4.0%.
  • Return on Capital Employed for Q2 2025 was 0.08% at Lifecore Biomedical, Inc. \De\, up from 0.09% in the prior quarter.
  • Over the last five years, Return on Capital Employed for LFCR hit a ceiling of 0.02% in Q4 2021 and a floor of 0.26% in Q4 2022.
  • Median Return on Capital Employed over the past 5 years was 0.08% (2023), compared with a mean of 0.08%.
  • Biggest five-year swings in Return on Capital Employed: fell -24bps in 2022 and later increased 14bps in 2023.
  • Lifecore Biomedical, Inc. \De\'s Return on Capital Employed stood at 0.02% in 2021, then tumbled by -1030bps to 0.26% in 2022, then surged by 56bps to 0.11% in 2023, then soared by 50bps to 0.06% in 2024, then tumbled by -45bps to 0.08% in 2025.
  • The last three reported values for Return on Capital Employed were 0.08% (Q2 2025), 0.09% (Q1 2025), and 0.06% (Q4 2024) per Business Quant data.